Infusion Systems Market in Japan 2016-2020

  • ID: 3775998
  • Report
  • Region: Japan
  • 62 pages
  • TechNavio
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 5

FEATURED COMPANIES

  • and Smiths Medical
  • Animas
  • B Braun Melsungen
  • Baxter
  • BD
  • Fresenius Kabi
  • MORE
About the Infusion Systems Market in Japan

An infusion system is an external pump used to deliver regulated amounts of drugs and nutrients to individuals through intravenous, epidural or enteral, and subcutaneous routes. Drugs delivered using the system include antibiotics, insulin and other hormones, pain relief medications, and chemotherapeutics. The system involves the use of needles for the intermediate active transport of drugs and fluids across biological membranes. Infusions pumps help administer fluids in situations where other methods are not feasible. For instance, infusion systems can deliver fluids at rates as low as 0.1 ml/hour.

The analysts forecast the infusion systems market in Japan to grow at a CAGR of 6.62% during the period 2016-2020.

Covered in this report
The report covers the present scenario and the growth prospects of the infusion systems market in Japan for 2016-2020. To calculate the market size, we consider revenue generated from the sales of:
- General purpose or volumetric pumps
- Syringe drivers
- Patient-controlled analgesia pumps
- Ambulatory pumps

The report, Infusion Systems Market in Japan 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
- B. Braun Melsungen
- Baxter
- BD
- Fresenius Kabi
- Hospira
- JMS
- Nipro
- Terumo

Other prominent vendors
- Animas
- Medtronic
- Smiths Medical

Market drivers
- Increasing use of chemotherapy
- For a full, detailed list, view the full report

Market challenges
- Complications of infusion systems
- For a full, detailed list, view the full report

Market trends
- Integration of IT-enabled devices
- For a full, detailed list, view the full report

Key questions answered in this report
- What will the market size be in 2020 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • and Smiths Medical
  • Animas
  • B Braun Melsungen
  • Baxter
  • BD
  • Fresenius Kabi
  • MORE
PART 01: Executive summary
  • Highlights
PART 02: Scope of the report
  • Market overview
  • Top-vendor offerings
PART 03: Market research methodology
  • Research methodology
  • Economic indicators
PART 04: Introduction
  • Key market highlights
PART 05: Market profile: Japan
  • Economy, business, and development
PART 06: Healthcare system in Japan
  • Role of government
PART 07: Key insights

PART 08: Complications of infusion systems: A global perspective
  • Background
  • Incidence of HAIs
  • CAUTIs
PART 09: Market landscape
  • Market overview
  • Market size and forecast
  • Five forces analysis
PART 10: Market segmentation by product
  • General purpose or volumetric pumps
  • Syringe drivers
  • Patient-controlled analgesia pumps
  • Ambulatory pumps
PART 11: Market segmentation by application
  • Analgesia or pain management
  • Diabetes
  • Oncology
  • Gastroenterology
  • Hematology
  • Pediatric or neonatology
PART 12: Market drivers
  • High prevalence of chronic diseases
  • Increasing use of chemotherapy
  • Rise in geriatric population
  • Favorable market conditions
PART 13: Impact of drivers

PART 14: Market challenges
  • Complications of infusion systems
  • Catheter-related bloodstream infections
  • Regulatory concerns and product recalls
  • Price wars
PART 15: Impact of drivers and challenges

PART 16: Market trends
  • Use of power-driven and closed infusion systems
  • Availability of IT-enabled devices
  • Focus on alternative site and homecare services
PART 17: Vendor landscape
  • Competitive scenario
  • B. Braun Melsungen
  • Baxter
  • BD
  • Fresenius Kabi
  • Hospira
  • JMS
  • Nipro
  • Terumo
  • Other prominent vendors
PART 18: Appendix
  • List of abbreviations
PART 19: About the Author

Exhibit 01: Product offerings
Exhibit 02: Acceptable pressure rates for infusion systems
Exhibit 03: Maximum resistance during infusion therapy
Exhibit 04: Japan: Facts and figures
Exhibit 05: Japan: Characteristics of market
Exhibit 06: Key strategies for market entry
Exhibit 07: Advantages and disadvantages of business models for vendors
Exhibit 08: Comparison of HAI in developed and middle and low income countries
Exhibit 09: Evidence-based risk factors for CAUTIs
Exhibit 10: Infusion systems market in Japan 2015-2020 ($ millions)
Exhibit 11: Market metrics for infusion systems in japan
Exhibit 12: Five forces analysis
Exhibit 13: Segmentation of infusion systems market in Japan by product
Exhibit 14: Metrics analysis of general purpose or volumetric pumps
Exhibit 15: Metrics analysis of syringe drivers
Exhibit 16: Metrics analysis of patient-controlled analgesia pumps
Exhibit 17: Metrics analysis of ambulatory pumps
Exhibit 18: Segmentation of infusion systems market in Japan by product 2015
Exhibit 19: Segmentation of infusion systems market in Japan by application
Exhibit 20: Impact of drivers
Exhibit 21: Impact of drivers and challenges
Exhibit 22: B. Braun Melsungen: Key takeaways
Exhibit 23: Baxter: Key takeaways
Exhibit 24: BD: Key takeaways
Exhibit 25: Fresenius Kabi: Key takeaways
Exhibit 26: Hospira: Key takeaways
Exhibit 27: JMS: Key takeaways
Exhibit 28: Nipro: Product offerings
Exhibit 29: Nipro: Key takeaways
Exhibit 30: Terumo: Product offerings
Exhibit 31: Terumo: Key takeaways
Exhibit 32: Other prominent vendors
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • and Smiths Medical
  • Animas
  • B Braun Melsungen
  • Baxter
  • BD
  • Fresenius Kabi
  • MORE
New Report Released: – Infusion Systems Market in Japan 2016-2020

The author of the report recognizes the following companies as the key players in the infusion systems market in Japan: B. Braun Melsungen, Baxter, BD, Fresenius Kabi, Hospira, JMS, Nipro, and Terumo.

Other Prominent Vendors in the market are: Animas, Medtronic, and Smiths Medical.

Commenting on the report, an analyst from the research team said: “A trend which is positively impacting the market is the availability of IT-enabled devices. Advances in technology and incorporation of IT-enabled components have significantly increased the efficiency of infusion systems. IT-enabled infusion systems offer advanced features, such as automatic recording of information regarding fluid flow, and optimal use of nutrients, fluid, and blood with less wastage and leakage. These features help enhance patient safety, reduce medical errors, increase the efficacy of dosages, and streamline information processing. IT-enabled infusion systems also help reduce costs and timelines associated with treatments.”

According to the report, a key growth driver is the rising use of chemotherapy. Over the past few years, chemotherapy is gaining popularity as a treatment option for cancer. The therapy involves the infusion of cytotoxic anti-neoplastic drugs and other medications directly into the bloodstream to inhibit the growth and spreading of cancer cells. Infusion systems provide short-term access to the bloodstream. Physicians use these systems to deliver chemotherapeutic agents to individuals receiving chemotherapy once every few weeks. Integrated or closed catheters offer fully (360 degrees) encased needle tip protection and have a passive design to minimize needle-stick injuries.

Further, the report states that one challenge that could restrict market growth is the complications associated with infusion systems.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 5
- B Braun Melsungen
- Baxter
- BD
- Fresenius Kabi
- Hospira
- JMS
- Nipro
- Terumo
- Animas
- Medtronic
- and Smiths Medical
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll